Lightstone Ventures’ Post

Most viewed in the last 7 days from JAMA Oncology: Is a ctDNA-guided adaptive de-escalation TKI strategy clinically feasible for radiologically undetectable advanced NSCLC after targeted and local consolidative therapy? https://ja.ma/3zd0TzH

Today, we shared data from our latest #stomachcancer immunotherapy study. Yelena Janjigian will present the data in American Society of Clinical Oncology (ASCO) Monthly Plenary Series. Read the results now: https://bit.ly/47m8is5

New data from our study in people with KRAS G12C-mutant advanced solid tumors, including in #NonSmallCellLungCancer (NSCLC), will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.    Learn more about the results: https://e.lilly/3V892g9 #ASCO24  

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC. Ramalingam’s American Society of Clinical Oncology (ASCO) plenary lecture receives standing ovation—20 years after EGFR discovery. https://lnkd.in/e5PNFzGB

American Society of Clinical Oncology (ASCO) GI 2024 wrapped up last weekend, but the insights continue! 💫 LARVOL CLIN analyzed discussions from 2500+ leading oncologists on X, focusing on the top trials at ASCO GI. Dive into what experts are saying about the latest in oncology. Learn more here: https://bit.ly/48ZTz6X #ASCO #GI24 #OncologyTrends #LARVOLCLIN

This quarter, our clinical-stage asset had a poster presentation at the 65th ASH Annual Meeting in December 2023. Enrollment in Studies ISB 1442-101 and ISB 2001-101 is proceeding well. These are some of the many strides we took in our goal to develop curative therapies in oncology. Find our Quarterly Update here: https://lnkd.in/dBhgwwKG #QuarterUpdate #BiotechUpdate #IchnosGlenmarkInnovation; American Society of Hematology

More on the results of @GOG #3055, #selinexor as maintenance tx for #endometrialcancer! Now online in @JCO_ASCO. We look forward to the confirmatory trial @GOG #3083. #clinicaltrials #gyncsm The GOG Foundation, Inc, Journal of Clinical Oncology

Single-arm clinical trials are gaining attention as potential registrational studies in oncology research. Want to know how often products based on these types of studies are approved? To find out, watch a video from a webinar on 'Single-Arm Studies for use as a Registrational Study in Oncology' 📽️ > https://bit.ly/3Huv46p #VeristatYouTube #SingleArmStudies #ClinicalTrials

LARVOL CLIN has compiled insights from over 2,500 oncologists on X, highlighting the top trials in GU Oncology.  We’ll keep them coming in all the major oncology areas.  Check out LARVOL CLIN here: clin.larvol.com #OncologyInsights #LARVOLCLIN

ASH 2023 wrapped up today, but the insights continue! 💫 LARVOL CLIN analyzed discussions from 2500+ leading oncologists on X, focusing on the top trials at ASH. Dive into what experts are saying about the latest in oncology. Learn more here: https://bit.ly/3NfrEYk #ASH23 #OncologyTrends #LARVOLCLIN